; Genomics Personalized Health Market Size, Industry Share, Forecast, 2032

Genomics Personalized Health Market

Genomics Personalized Health Market: Segmented: By Test Type (Oncology Testing, Infectious Disease Testing, Orphan Disease Testing, Autoimmune Disease Testing, Obstetrics Testing, Others), By Technology (NGS Platforms, RT-PCR, Microarray, Genetic Analyzers), By End User (Academic Research Institutes, Diagnostic Centers, Others), And Region - Global Analysis Of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032

Published on: Nov-2022
Report Code: FG HC 01255
No. of Pages: 170-350
Report Format: PDF

[ 170 + Pages Research Report ] Genomics Personalized Health Market to surpass USD 31.46 Billion by 2032 from USD 8.59 Billion in 2021 at a CAGR of 12.5% in the coming years, i.e., 2022-32.

Product Overview

Personalized medicine is a developing medicine practice that uses a person’s genetic profile to escort the decisions made for the diagnosis, prevention, and cure of disease. Doctors can choose the best treatment and deliver it with the right dosage or regimen by having the right knowledge of the genetic profile of a patient. Since genomics gives us a very specific molecular window for the differences between us and allows the experts to make individualized predictions about disease risk, which can help someone choose the right prevention plan for them, genomics has a significant impact on the development of personalized medicine.

Market Highlights

The Genomics Personalized Health Market is expected to project a notable CAGR of 12.5% in 2032.

The expanding biopharmaceutical and healthcare industries as well as technological advancements are expected to fuel the growth of the Genomics Personalized Health Market during the forecast period.

Genomics Personalized Health Market: Segments

The NGS Platforms segment is expected to grow with a higher CAGR during 2022-32

Genomics Personalized Health market is categorized on the basis of Technology into NGS Platforms, RT-PCR, Microarray, and Genetic Analyzers. In previous years, the NGS platform category held a sizeable market share. During the projection period, this sector is anticipated to rise rapidly owing to the launch of highly effective technologies and instruments by top players in the market. The top-selling and most innovative sequencing products for various genetic analyses are also included in this area.

The Academic Research and Diagnostic Centers segments are expected to grow with a higher CAGR during 2022-32

Genomics Personalized Health market is categorized on the basis of End User into Academic Research Institutes, Diagnostic Centers, and Others. The academic research institutes and diagnostic centers are expected to lead the market over the forecast period, all of which held a significant market share in previous years. In the coming years, these categories are anticipated to be driven by rising genomics research activities, rising genetic disorders, rising strategic alliances between market leaders, and rising research institutes.

Market Dynamics

Drivers

The Growing Geriatric Population Worldwide and Technological Advancements in the Domain

Globally, the geriatric population is experiencing a variety of chronic conditions that require surgery in order to relieve pain and improve their quality of life. Therefore, it is anticipated that a rise in the prevalence of several chronic diseases, including cancer and diabetes, will fuel the genomics personalized health market. In addition, it is expected that increased government and diagnostic healthcare spending would play a significant role in fostering the expansion of the market. The genomics personalized health market is also projected to be driven by the rising research expenditures and technological advancements.

The Expansion of the Biopharmaceutical and the Healthcare Industry

The market is anticipated to increase due to the expansion of the pharmaceutical industry and assessments and responses to treatment outcomes. Moreover, the dynamic molecular biology market and technological advancements in the healthcare sector have a significant impact on the genomics personalized health market. As a result, the growth of the biopharmaceutical and healthcare industries will generate a significant incremental opportunity for the global genomics personalized health market in the years to come.

Restraint

Improper Reimbursement Policies are hindering the Market Growth

The complicated regulatory framework that contributes to delaying the approval of new techniques is one of the main restraints of the market growth. Inadequate reimbursement regulations are just another barrier restraining the market from developing remarkably in the future. This negative factor is particularly noticeable throughout the development stage.

Recent Developments

  • NorthShore Taps Sema4 launched ‘System-Wide Genomics Program’ in April 2021. The program will use predictive analytics to deliver targeted treatment regimens to prevent and treat diseases in their early stages, when they are most treatable.
  • In February 2021, the partnership between Quantgene and Vikor Scientific launched ‘Serenity’ a game-changing development in precision genomics and tailored medicine. It uses liquid biopsy to detect cancer-associated mutations in the blood to help in early detection.

Genomics Personalized Health Market: Key Players

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Vikor Scientific
  • Roche Holding AG
  • Qiagen
  • Quantgene
  • Bio-Rad Laboratories Inc.
  • Lonza Group AG
  • ARCA biopharma
  • Invitae Corporation
  • Genetic Technologies Limited
  • Interleukin Genetics Inc.
  • Eastern Biotech and Life Sciences
  • DNA Genotek Inc.
  • XCode Life Sciences Private Limited.
  • Other Prominent Players

Genomics Personalized Health Market: Regions

Genomics Personalized Health market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa.. North America held a significant share of the global market for genomics personalized health market due to increased knowledge and rising healthcare costs in the region. Another factor contributing to the market growth is the rising number of pharmaceutical and biotechnology companies in Brazil and Mexico which have offered lucrative growth opportunities in the market. Latin America is also expected to witness a considerable share owing to the growing awareness and rising healthcare costs.

Impact of Covid-19 on Genomics Personalized Health Market

Due to lockdowns and business closures, the pandemic had a major impact on the economies and sectors of different nations. The production and sales of goods in the Genomics Personalized Health market were disrupted by the closure of various plants and factories, which also impacted the global supply chains. A few businesses have already reported that future sales would decline and that their product delivery will be delayed. As a result, the pandemic has slowed the market's growth over the course of the projection period due to the aforementioned factors.

Genomics Personalized Health Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Genomics Personalized Health Market report also contains analysis on:

Genomics Personalized Health Market Segments:

  • By Test Type 
    • Oncology Testing
    • Infectious Disease Testing
    • Orphan Disease Testing
    • Autoimmune Disease Testing
    • Obstetrics Testing
    • Others 
  • By Technology 
    • NGS Platforms
    • RT-PCR
    • Microarray
    • Genetic Analyzers 
  • By End User
    • Academic Research Institutes
    • Diagnostic Centers
    • Other 
  • Genomics Personalized Health Market Dynamics
  • Genomics Personalized Health Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Genomics Personalized Health Market Report Scope and Segmentation

Report Attribute Details
Market size value in 2021 USD 8.59 Billion
Revenue forecast in 2032 USD 31.46 Billion
Growth Rate CAGR of 12.5% from 2022 to 2032
Base year for estimation 2021
Quantitative units Revenue in USD million and CAGR from 2022 to 2032
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered Test Type, Technology, End User, and Region
Regional scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled Thermo Fisher Scientific Inc., Illumina Inc., Vikor Scientific, Roche Holding AG, Qiagen, Quantgene , Bio-Rad Laboratories Inc., Lonza Group AG, ARCA biopharma, Invitae Corporation, Genetic Technologies Limited, Interleukin Genetics Inc., Eastern Biotech and Life Sciences, DNA Genotek Inc., XCode Life Sciences Private Limited., and Other Prominent Players.

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients